Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1

The number of patients with diabetic nephropathy (DN) is still on the rise worldwide, and this requires the development of new therapeutic strategies. Recent reports have highlighted genetic factors in the treatment of DN. Herein, we aimed to study the roles of long noncoding RNA (lncRNA) plasmacyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dong-Wei, Zhang, Jia-Hui, Liu, Feng-Xun, Wang, Xu-Tong, Pan, Shao-Kang, Jiang, Deng-Ke, Zhao, Zi-Hao, Liu, Zhang-Suo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802617/
https://www.ncbi.nlm.nih.gov/pubmed/31371698
http://dx.doi.org/10.1038/s12276-019-0259-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802617/
https://www.ncbi.nlm.nih.gov/pubmed/31371698
http://dx.doi.org/10.1038/s12276-019-0259-6

Ejemplares similares